Galapagos NV
GLPG
#4560
Rank
ยฃ1.58 B
Marketcap
ยฃ23.78
Share price
0.41%
Change (1 day)
13.19%
Change (1 year)

P/E ratio for Galapagos NV (GLPG)

P/E ratio as of December 2025 (TTM): -93.4

According to Galapagos NV's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -93.448. At the end of 2024 the company had a P/E ratio of 23.4.

P/E ratio history for Galapagos NV from 2015 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202423.4104.48%
202311.5-191.92%
2022-12.5-59.81%
2021-31.079.18%
2020-17.3-124.16%
201971.6-150.69%
2018-141323.07%
2017-33.4-164.57%
201651.7-399.85%
2015-17.2-222.8%
201414.0-125.86%
2013-54.3-27%
2012-74.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
AstraZeneca
AZN
29.7-131.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
19.3-120.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.0-113.90%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
165-276.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-1.96-97.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
15.1-116.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
45.4-148.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
13.2-114.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
12.8-113.66%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.